© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
10-Q | Quarterly report which provides a continuing view of a company's financial position |
View HTML EX-101.INS | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
SC 14F1 | Statement regarding change in majority of directors pursuant to Rule 14f-1 |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% |
View HTML | |
SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% |
View HTML | |
SC 13D | Filing by person(s) reporting owned shares of common stock in a public company >5% |
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
View HTML | |
3 | Initial filing by director officer or owner of more than ten percent. |
View HTML |
Data provided by Kaleidoscope.